Advertisement
Advertisement
U.S. markets open in 4 hours 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Curis, Inc. (CRIS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.8800+0.0400 (+0.83%)
At close: 04:00PM EST
4.8800 0.00 (0.00%)
Pre-Market: 04:17AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.8400
Open4.8100
Bid0.0000 x 1100
Ask5.1000 x 1100
Day's Range4.6650 - 4.9400
52 Week Range1.0900 - 17.4000
Volume1,755,833
Avg. Volume1,418,545
Market Cap447.053M
Beta (5Y Monthly)2.80
PE Ratio (TTM)N/A
EPS (TTM)-0.4620
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CRIS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Curis, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
Advertisement
Advertisement